Surgery in Advanced Disease (Testicular Cancer)

Testicular cancer: improving outcomes with national quality performance indicators

BMJ Open Quality ◽

10.1136/bmjoq-2019-000726 ◽

2020 ◽

Vol 9 (1) ◽

pp. e000726

Author(s):

Mark A Baxter ◽

Graham MacDonald ◽

Jahangeer Malik ◽

Alistair Law ◽

Åsa Dahle-Smith ◽

...

Keyword(s):

Testicular Cancer ◽

Performance Indicators ◽

Advanced Disease ◽

Demographic Data ◽

Developed Countries ◽

Limited Disease ◽

Quality Performance ◽

Adult Men ◽

National Quality ◽

Common Malignancy

Testicular cancer is the most common malignancy in young adult men. The prognosis is excellent in limited disease and cure is possible even in advanced disease. Quality performance indicators (QPI) are used in many developed countries as a measure of healthcare performance. We report and discuss the development of a national set of QPIs in Scotland for testicular cancer as a method of gathering demographic data and driving improvement in nationwide testicular cancer outcomes.

Download Full-text

Optimal management of testicular cancer: from self-examination to treatment of advanced disease

Open Access Journal of Urology ◽

10.2147/oaju.s7174 ◽

2010 ◽

pp. 143 ◽

Cited By ~ 1

Author(s):

Stephen Beck

Keyword(s):

Testicular Cancer ◽

Advanced Disease ◽

Optimal Management ◽

Self Examination

Download Full-text

Part II: Testicular cancer—management of advanced disease

The Lancet Oncology ◽

10.1016/s1470-2045(03)01279-8 ◽

2003 ◽

Vol 4 (12) ◽

pp. 738-747 ◽

Cited By ~ 40

Author(s):

Robert H Jones ◽

Paul A Vasey

Keyword(s):

Testicular Cancer ◽

Advanced Disease ◽

Cancer Management

Download Full-text

Treatment of Disseminated Germ Cell Tumors With Cisplatin, Bleomycin, and Either Vinblastine or Etoposide

50 Studies Every Urologist Should Know ◽

10.1093/med/9780190655341.003.0031 ◽

2021 ◽

pp. 177-182

Author(s):

Michael Risk

Keyword(s):

Adverse Effects ◽

Testicular Cancer ◽

Germ Cell ◽

Induction Chemotherapy ◽

Chemotherapy Regimen ◽

Advanced Disease ◽

Germ Cell Tumors ◽

Equivalent Efficacy ◽

Versus Treatment ◽

Metastatic Testicular Cancer

This chapter reviews a landmark trial that randomized patients with disseminated testicular cancer to treatment with cisplatin, etoposide, and bleomycin (BEP) versus treatment with cisplatin, vinblastine, and bleomycin (PVB). This study demonstrated BEP to be superior to PVB in terms of adverse effects in this trial, with at least equivalent efficacy if not superiority in the setting of advanced disease. This study established BEP as the standard induction chemotherapy regimen used for the majority of patients with metastatic testicular cancer.

Download Full-text